| Balance Sheets | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 47,120 | 72,740 | 53,104 | 134,851 |
| Restricted cash | 308 | 308 | 617 | 617 |
| Marketable securities | 143,948 | 118,083 | 144,984 | 195,710 |
| Trade receivables, net | 115,116 | 106,688 | 85,415 | 60,119 |
| Inventories | 22,419 | 16,324 | 16,614 | 14,015 |
| Prepaid expenses and other current assets | 20,313 | 18,635 | 22,937 | 18,408 |
| Total current assets | 349,224 | 332,778 | 323,671 | 423,720 |
| Property, plant, and equipment, net | 1,215 | 1,394 | 1,496 | 1,186 |
| Intangible assets, net | 15,375 | 15,937 | 16,500 | 9,792 |
| Operating lease right-of-use asset | 4,567 | 1,728 | 1,842 | 2,060 |
| Other assets | 596 | 596 | 596 | 596 |
| Total assets | 370,977 | 352,433 | 344,105 | 437,354 |
| Accounts payable | 5,795 | 15,082 | 24,529 | 19,325 |
| Current portion of long-term debt, net | 1,000 | 1,000 | - | 99,513 |
| Accrued and other current liabilities | 92,975 | 87,854 | 65,758 | 52,790 |
| Operating lease liability | - | - | 842 | 798 |
| Total current liabilities | 99,770 | 103,936 | 91,129 | 172,426 |
| Operating lease liability, long-term | 5,276 | 2,114 | 2,340 | 2,772 |
| Long-term debt, net | 107,498 | 107,049 | 107,618 | 105,095 |
| Other long-term liabilities | 360 | 360 | 360 | 420 |
| Total liabilities | 212,904 | 213,459 | 201,447 | 280,713 |
| Common stock, 0.0001 par value 300,000,000 shares authorized at september30, 2025 and december31, 2024 120,288,146 and 117,848,033 shares issued and outstanding at september30, 2025 and december31, 2024, respectively | 12 | 12 | 12 | 12 |
| Additional paid-in capital | 1,313,602 | 1,301,886 | 1,289,789 | 1,267,251 |
| Accumulated other comprehensive loss | -62 | -35 | -140 | 533 |
| Accumulated deficit | -1,155,479 | -1,162,889 | -1,147,003 | -1,111,155 |
| Total stockholders equity | 158,073 | 138,974 | 142,658 | 156,641 |
| Total liabilities and stockholders equity | 370,977 | 352,433 | 344,105 | 437,354 |
Arcutis Biotherapeutics, Inc. (ARQT)
Arcutis Biotherapeutics, Inc. (ARQT)